Search

Your search keyword '"Pardo, Nuria"' showing total 214 results

Search Constraints

Start Over You searched for: Author "Pardo, Nuria" Remove constraint Author: "Pardo, Nuria"
214 results on '"Pardo, Nuria"'

Search Results

9. Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients

16. Data from Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

17. Table S2 from Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

18. Figure S4 from Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

19. Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

25. T-cell infiltration in matched samples from malignant pleural mesothelioma (MPM) during evolution of disease.

27. Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer

29. High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

37. Efficacy of Chemotherapy for Malignant Pleural Mesothelioma According to Histology

38. Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

40. Analysis of chemotherapy efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p).

43. Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

46. Propranolol for Infantile Hemangiomas

48. Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer

50. Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients.

Catalog

Books, media, physical & digital resources